Poseida Therapeutics Stock Forecast
Recent Poseida Therapeutics Stock Price |
|
Poseida Therapeutics Stock Forecast Price |
$3.08 |
+354.55% |
$14.00 |
As of 2024-03-28
Recent Poseida Therapeutics Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
5 |
5 |
5 |
5 |
Buy ratings: |
0 |
0 |
0 |
0 |
Hold ratings: |
0 |
0 |
0 |
0 |
Sell ratings: |
0 |
0 |
0 |
0 |
Strong sell ratings: |
0 |
0 |
0 |
0 |
Average rating: |
1.0 |
1.0 |
1.0 |
1.0 |
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.
The presented Poseida Therapeutics stock forecast (traded under symbol PSTX), for forward-twelve-months price target as shown at the top of this page, gives you the average Poseida Therapeutics stock forecast for forward target price for symbol PSTX, across the 3 analysts covering Poseida Therapeutics (PSTX), as reported in
data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Poseida Therapeutics stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Poseida Therapeutics stock forecast and half had a lower Poseida Therapeutics stock forecast) was $12.0 as of 2024-03-28 (which is a different mathematical metric versus taking the average or mean), while the
highest Poseida Therapeutics stock forecast in the analyst group was $20.0, and the lowest Poseida Therapeutics stock forecast in the analyst group was
$10.0, with a standard deviation of $5.291. Get the latest Zacks research report on PSTX — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
Company Name: |
Poseida Therapeutics Inc |
Website: |
www.poseida.com |
Sector: |
Biotechnology |
Number of ETFs Holding PSTX: |
11 |
Total Market Value Held by ETFs: |
$16.32M |
Total Market Capitalization: |
$271.00M |
% of Market Cap. Held by ETFs: |
6.02% |
|
|
March 29, 2024 3:15 AM Eastern
Strong Buy (4.00 out of 4)
82nd percentile
|
|